Dr. Huixiao Hong is a senior Scientist at National Center for Toxicological Research (NCTR), US Food and Drug Administration (FDA), Arkansas, USA, working on the scientific bases for regulatory application and development of genomics biomarkers. Before joining the FDA, he was the Manager of Bioinformatics Division at Z-Tech, an ICFI company, at NCTR. He held a Research Scientist position at Sumitomo Chemical Company in Japan. He was a visiting scientist at National Cancer Institute (NCI) at National Institutes of Health (NIH). He was also an Associated Professor and the Director of Laboratory of Computational Chemistry at Nanjing University in China. He published more than 140 scientific papers and served as Editor-in-Chief, Executive Editor and Editorial Board member for more than 10 peer-reviewed journals and as reviewer for more than 20 peer-reviewed journals. He received his Ph.D. from Nanjing University in China and did post-doctoral research at Maxwell Institute in Leeds University in England.

Biomarker

Anthia A. Zammit LL.B, LL.D counsels clients on regulatory law and global data privacy matters primarily in the healthcare; life sciences; biotechnology; pharmaceutical; food; and chemical industries. She represents a diverse client-base encompassing Swiss; French; German; UK; Belgian; Dutch; Israeli; Maltese, Latin American; and U.S. companies. Anthia served as legal counsel to the Healthcare Business Section of the Malta Chamber of Commerce, Enterprise, and Industry, and as a member of the European Patients’ Forum (EPF) Policy Advisory Committee. She previously worked in the Office of the CEO of the Medicines Authority (the “Maltese FDA”). Anthia’s profile was enhanced by her role in global supply chain expansion of private and publicly-listed companies in established and emerging markets, including the EU, U.S., and Latin America. Anthia is experienced in contract negotiation; medicinal product launches; drug and vaccine licensing; regulatory affairs; regulatory compliance; good manufacturing practice; good distribution practice; pharmacovigilance; pricing & reimbursement; and marketing. She is regularly a keynote speaker at high-level conferences on invitation of the European Commission. Anthia received an LL.B (Bachelor of Laws) and an LL.D (Doctor of Laws) from the University of Malta. Her doctoral dissertation Pharmaceutical Law in the EU and USA: The Impact on Public Health and the Pharmaceutical Industry, earned her the European Commission's and World Health Organisation’s European Health Forum Gastein Scholarship. Anthia is admitted to the practice of law in the Republic of Malta (a member state of the European Union), and is certified as a Legal Consultant by the Supreme Court of the State of New York, U.S. http://www.anthiazammit.com

Pharmaceutical Law, Drug Law, Health Law, Public Health, EU Healthcare, Pharmaceutical Industry, Regulatory Affairs, Pharmaceutical Licensing, Medicine Registration, Pharmaceutical Manufacturing, Pharma Marketing, Life Sciences, Biotech Industry, Malta Pharmacy, Malta Health, Medicinal Products, Product Launches, Supply Chain, Generic Drugs, Innovative Drugs, European Union, United States, Latin America.

Dr. Carmen Popescu got her B.S. degree in Physics and Ph.D. in Biophysics at University of Bucharest, Romania. She is a Senior Project Coordinator at Roquette America Inc. and Adjunct Associate Professor with University of Illinois at Chicago. Roosevelt University, University of Tennessee, University of Maryland.She has published over 120 research papers, book chapters and presentations on classic and new drug delivery dosage for small and large molecules. Additionally she is a reviewer for the International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences, European Journal of Pharmaceutics and Biopharmaceutics, Journal of Pharma & Pharmaceutical Science and an active member of AAPS and CRS.

Classic dosage forms (liquid, semi-solid, and solid dosage forms formulation) as well as drug delivery systems (microparticles, nanoparticles, liposomes, niozome, etc.) for small and large molecules.

Dr. Tejani-Butt is a Professor of Pharmacology and Toxicology. Her research areas include the regulation of biogenic amines in an animal model of depressive behavior, implications of these biogenic amines in modulating a stress response, reward and addictive behaviors, and the action of drugs in psychiatric disorders. Dr. Tejani-Butt has been the recipient of intramural and extramural grants for the past 25 years and published extensively in peer reviewed journals. Dr. Tejani-Butt received her PhD in Medicinal Chemistry from the Medical College of Virginia, her MS in Organic Chemistry and BS in Chemistry and Microbiology from the University of Bombay.

Neuropsychopharmacology, alcohol and substance abuse, stress and psychiatric disorders Molecular Mechanisms associated with the regulation of biogenic amines in an animal model of depressive behavior; implication of these biogenic amines in modulating a stress response, reward and addictive behaviors, as well as in the therapeutic action of drugs used to treat psychiatric disorders.

Dr. Dianqing Sun is an Associate Professor of Pharmaceutical Sciences at the Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo. Before joining UH-Hilo, Dr. Sun was a Research Associate in the Department of Pharmaceutical Sciences of the College of Pharmacy at University of Tennessee Health Science Center. Dr. Sun received his Master degree from East China University of Science and Technology and his Ph.D. from the University of Memphis in Organic Chemistry, and received his postdoctoral training in Medicinal Chemistry at the University of Tennessee. Research in his laboratory focuses on the discovery and development of novel small molecule and natural product-inspired antibacterial and anticancer agents

Organic Synthesis, Medicinal Chemistry, Antibacterial and Anticancer Drug Discovery

Prof. Jan Kyselovic, Pharm.D., Ph. D.- holds professor position of pharmacology and pharmacy and chair of postgraduate PhD course for Pharmacology in Comenius University Bratislava, Slovakia. He is EU expert EMA for Advanced Medicines. He was Research Fellow at postdoc stay at Ottawa University, Canada and Catholic University Brussels, Belgium. He is emeritus dean of Faculty Pharmacy. He leads a team of 15 scientists (2 associate professors, 6 assistant of professors, 7 PhD students) working on extrapolation of experimental and clinical pharmacology and molecular medicine. His innovations in this field led to the receipt of the more than 7 international and 14 domestic grants. He has been supervisor theses for more than 150 students, and authored/co-authored over 80 peer-reviewed full articles, 2 books co-author, 2 book co-editor and 6 textbooks.

Clinical and experimental pharmacology of cardiovascular regenerative medicine

Prof. Akiyama currently is General Director of the Saisei Mirai Clinic in Tokyo, Japan. Saisei Mirai Clinic is one of the most comprehensive innovative cancer therapy centers in Asia. He had been a fellow in oncology at Sapporo Medical University School of Medicine. This led to clarify intracellular TNF as a resistant factor by chemotherapeutic agents. He joined the Cancer Immune Cell Therapy Center of Kudan Clinic in 2009. There he had applied cancer gene profiling as therapeutic effect of peptide-pulsed dendritic cell therapy. He was selected as “Featured Global Expert Cancer Researcher of Marquis Who's Who” in 2015.

Oncology

Graduated from Hacettepe University, Ankara (BS. Pharmacy 1993, M. Sc. Pharmaceutical Chemistry 1995) and received Ph. D. on Pharmaceutical Chemistry (2000) from Hacettepe University, Ankara, Turkey. She was postoctoral fellow with Prof. Gerd Folkers at ETH-Zurich, Switzerland. She has been at Yeditepe University, Faculty of Pharmacy since 2005.

Research interests are molecular interaction between bioactive molecules and their targets. Specially interested in 3D-QSAR approches, docking and structure based drug design.

Ilkay Yildiz has completed her PhD in 1995 from Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry. She is full professor at the same department since 2004. She worked for Prof. Dr. James Snyder as a post-doctoral researcher at the Department of Chemistry, University of Emory, Atlanta-USA in 2000-2002. She worked as a Head of Department of Pharmaceutical Chemistry in 2011-2012. And she was a Vice Directory of Graduated School of Health Science at the University of Ankara at the same time. She is an Editorial Assistant for Journal of Faculty of Pharmacy of Ankara University since 2002. She published 76 articles. Her research interests: Design using CADD approach and synthesis of Topoisomerase I and II enzymes inhibitors, Glutation-S-Transferase Enzyme inhibitors, Efflux Pump inhibitors, Acetylcholinesterase inhibitors for Alzheimer’s Disease, Anticancer, Antiviral, and Antioxidant compounds.

Computer-aided drug design (2D QSAR (Free-Wilson and Hansch analysis), 3D QSAR CoMFA and CoMSIA, HipHop, HypoGen, molecular modelling, conformational analysis, molecular dynamics) * Computational Chemistry (Ab initio, Semiempirical, DFT) * Microbiological, Antitumoral, Antiviral, and Antioxidant activities * Structure Analysis (IR, 1H NMR, Mass) and Synthesis of heterocyclic compounds

Oya BOZDAÄž DÃœNDAR has completed her PhD from Ankara University. She has been lecturing to B.Sc., M.Sc. and Ph. D. students in Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry. She is interested with drug design and synthesis of heterocyclic compounds having antidiabetic, aldose-reductase enzyme inhibitory, antioxidant, histon deasetilase enzyme inhibition, anticancer activities.

drug design and synthesis of heterocyclic compounds having antidiabetic, aldose-reductase enzyme inhibitory, antioxidant, histon deasetilase enzyme inhibition, anticancer activities.

Professor Sivakumar Manickam (Siva) is a Chemical Engineer who specializes on the Process Engineering of Nanomaterials especially Nanopharmaceuticals. His research group concentrates on the process development of cavitation based reactors (ultrasound and large scale hydrodynamic cavitation) towards technologically important nanomaterials and to treat the wastewater. His research team has developed a number of nanoformulations incorporated with active ingredients using the cavitation technology. Recent research also involves using nanocarbon materials such as CNT, Graphene and Fullerene for drug delivery and in the development of biosensor for early detection of cancer. He is heading the Manufacturing and Industrial Processes Research Division and is the Coordinator of the Centre for Nanotechnology and Advanced Materials (CENTAM). He is in the editorial board of various journals. He has published ~200 peer reviewed journal and conference papers. He is the recipient of several prizes, awards and fellowships including JSPS fellowship, Japan. He is a Fellow of Higher Education Academy (FHEA, UK) and a member of Institute of Nanotechnology (IoN). He organizes workshops and conferences and recently he chaired the 2nd Asia-Oceania Sonochemical conference at Kuala Lumpur.

Nanopharmaceutical formulations; Nanobiosensor for cancer and diabetes detection; Nanopharmaceuticals

Bahubali G. Nagavi has completed his PhD at the age of 29 years from BITS, Pilani, India. He has more than 36 years of teaching & research experience. Since 2007 Dr. Nagavi is working as Professor and Dean, RAK College of Pharmaceutical Sciences, RAK Medical & Health Sciences University, RAK, UAE. He has guided 35 PG’s and 05 Ph.D.’s. He was Editor of Indian Journal of Pharmacy Education and Research (IJPER) from 1997 to 2007. He has about 67 national and 12 international publications. He is a recipient of Distinguished Teacher Award of Assoc. of Pharm Teachers of India (APTI) in 1998 and has a Patent and Trade mark registration to his credit.

Patient counseling, DI services, ADR reporting & monitoring In community pharmacy; Curriculum design & education research

Prof Mohamed AA Moustafa has completed his Pharmacy education in Cairo University, and earned his PhD from School of Pharmacy at Université Catholique de Leuven, Belgium. He is a permanent professor of medicinal chemistry at Faculty of Pharmacy, Mansoura University, Egypt. Since 2011/2012 till now he is the chairman of pharmaceutical chemistry department, and director of the quality and academic accreditation unit of the Faculty of Pharmacy at King Abdulaziz University, KSA. He has more than 60 publications and has been serving as editorial board member of Journal of Pharmaceutical Care and Health Systems and Journal of Pharmaceutics and Drug Development.

Journal of Pharmaceutical Care and Health Systems and Journal of Pharmaceutics and Drug Development.

George Perry (born April 12, 1953 in Lompoc, California) is a neuroscientist recognized in the field of Alzheimer's disease research particularly for his work in oxidative stress. Dr. Perry has studied at many universities and holds multiple degrees including a Bachelor of Arts degree in Zoology from the University of California Santa Barbara and a PhD in Marine Biology from the University of California at San Diego. He is distinguished as one of the top Alzheimer’s disease researchers with over 1000 publications, more than 60,000 citations, one of the top 100 most-cited scientists in Neuroscience & Behavior and one of the top 25 scientists in free radical research. Dr. Perry is a Semmes Foundation Distinguished chair in Neurobiology and is an active participant in many other scientific associations. In addition, Perry is an Editor of numerous scientific journals including Journal of Alzheimer’s Disease which he founded in 1998. Today, Perry continues his love for research while working as Dean of the College of Sciences at The University of Texas at San Antonio.

All of Dr. Perry’s research is centered around Neurodegeneration. In particular, Dr. Perry focuses mostly on Alzheimer’s disease and the effects of oxidative stress on the disease as well as its effects on other neurodegenerative disorder.

George Perry (born April 12, 1953 in Lompoc, California) is a neuroscientist recognized in the field of Alzheimer's disease research particularly for his work in oxidative stress. Dr. Perry has studied at many universities and holds multiple degrees including a Bachelor of Arts degree in Zoology from the University of California Santa Barbara and a PhD in Marine Biology from the University of California at San Diego. He is distinguished as one of the top Alzheimer’s disease researchers with over 1000 publications, more than 60,000 citations, one of the top 100 most-cited scientists in Neuroscience & Behavior and one of the top 25 scientists in free radical research. Dr. Perry is a Semmes Foundation Distinguished chair in Neurobiology and is an active participant in many other scientific associations. In addition, Perry is an Editor of numerous scientific journals including Journal of Alzheimer’s Disease which he founded in 1998. Today, Perry continues his love for research while working as Dean of the College of Sciences at The University of Texas at San Antonio.

All of Dr. Perry’s research is centered around Neurodegeneration. In particular, Dr. Perry focuses mostly on Alzheimer’s disease and the effects of oxidative stress on the disease as well as its effects on other neurodegenerative disorder.

Dr. Mirza R. Baig is currently working as a Professor in Clinical Pharmacy in Dubai Pharmacy College, Dubai, United Arab Emirates. He did his PhD in Clinical Pharmacy from University Science Malaysia (USM), Malaysia. He worked in Malaysia, India and have international teaching experience of about 14 years. He worked as an Acting Dean for a brief period in AIMST University, Malaysia. He published 4 books related to Clinical Pharmacy and Pharmaceutical Care. He published more than 30 Research papers and articles in International Journals. He is in the editorial board in various international journals and He is a reviewer for couple of Elsevier journals. He supervised many master and PhD students for their research projects. He also reviewed several Master and PhD thesis as an external examiner. He received couple of awards in his career, one of it as a young scientist award in Malaysia, Best Presentation for the research project in DUPHAT 2015 in Dubai, Best presentation award in IPC 2003, in India.

Pharmacoepidemiology of endocrine disorders, Drug Utilization Studies, Pharmacoeconomic evaluations and Public health

Yalda Shokoohinia has completed her Pharm D in 2005 and her PhD in 2011 both from Isfahan University of medical sciences. She started as an assistant professor in Kermanshah University of Medical Sciences in 2011 and awarded as associate professor in 2015. She has been the head of department of Pharmacognosy & Biotechnology from 2013 to 2015. She has beenalso head of continuous medical education of Kermanshah University of Medical Sciences from 2015. She has published more than 34 articles indexed in ISI web of science, Pubmed, Scopus , etc and has supervised more than 30 theses of Pharm D and MSc students.

• Isolation and structure elucidation of terpenoids and coumarins from medicinal plants • Spectroscopy analyses esp. NMR analysis of natural products esp. terpenoids • Multidimensional chromatography • Formulation of folk and traditional based herbal remedies

Dr. Manju Sharma, Assistant Professor (Pharmacology) is involved in teaching & research in Hamdard University, New Delhi for past 20 years. She has guided 28 M.Pharm. and 12 PhD research projects till now. She has been invited as guest speaker at various national and international conferences. Dr. Manju Sharma has published number of research papers in National and International journals. She received AICTE Career Award for Young Teachers (CAYT-2009) and Uppasala Best Paper Award by Society of Pharmacovigilance (India). She has received Science and Engineering Research Board (SERB) Travel Grant, DST, Govt. of India, for presenting her work at ATTD-2012, Spain.

Pharmacology & Toxicology, Apitherapy in Hepatotoxicity, Antioxidants in Diabetes Management, Pharmacological Intervention in Diabetes Mellitus, Free Radicals & Antioxidants, Cardiovascular Pharmacology, Drug Interaction studies with antidiabetic Drugs, Pharmacovigilance studies – ADR Monitoring, Drug Utilization Studies (DUS).